TETRAPHASE PHARMACEUTICALS INC Accrued Liabilities, Current
TETRAPHASE PHARMACEUTICALS INC had Accrued Liabilities, Current of $5.24 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-05-07
- 2020-03-31: Accrued Liabilities, Current $5.24M.
- 2019-12-31: Accrued Liabilities, Current $5.79M.
- 2019-09-30: Accrued Liabilities, Current $8.57M.
- 2019-06-30: Accrued Liabilities, Current $11.82M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2020-03-31 | $5.24M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $5.79M 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $8.57M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $11.82M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.26M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $11.76M 10-K · filed 2020-03-12 | $11.75M 10-K · filed 2019-03-15 |
| 2018-09-30 | $9.19M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $8.73M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $6.12M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $12.56M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $12.89M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $12.12M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $11.77M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $7.68M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $6.21M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $6.61M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $7.37M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $6.93M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $8.52M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $9.37M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $9.06M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $9.48M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $5.52M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $5.96M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $4.08M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $5.29M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $4.48M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.23M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $1.97M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $2.30M 10-K · filed 2014-03-06 |